Article Text

PDF

1.3 DNA Methylation of Somatotropic Axis Genes in Relation to Postnatal Growth and Metabolism Following Ad.VEGF Treatment of Growth-Restricted Sheep Fetuses
  1. DJ Carr1,2,
  2. RP Aitken2,
  3. JS Milne2,
  4. DM Peebles1,
  5. JF Martin3,4,
  6. IC Zachary3,
  7. JM Wallace2,
  8. AL David1
  1. 1Prenatal Therapy Group, UCL Institute for Women’s Health, London, UK
  2. 2Rowett Institute of Nutrition and Health, University of Aberdeen, Aberdeen, UK
  3. 3Centre for Cardiovascular Medicine & Biology, UCL, London, UK
  4. 4CSO, Ark Therapeutics, London, UK

Abstract

Introduction We previously showed that adenovirus (Ad) mediated overexpression of vascular endothelial growth factor (VEGF) in the uteroplacental circulation increases fetal growth velocity in the overnourished adolescent sheep paradigm of fetal growth restriction1 2. Lambs born following Ad.VEGF therapy also demonstrated accelerated lean tissue accretion and enhanced insulin secretion following glucose challenge3. Herein we examined for putative epigenetic changes underlying these postnatal effects by quantification of methylation at cytosine:guanine (CpG) dinucleotides.

Methods DNA was extracted from liver samples obtained at 82 ± 0.2d postnatal age in 29 lambs born after prenatal treatment with Ad.VEGF (n = 16: 8 × Male/8 × Female) or Saline (n = 13: 7 × Male/6 × Female). After incubation with sodium bisulphite, PCR was performed using custom-designed primers targeting 9 CpG islands across 5 genes: insulin, growth hormone, insulin-like growth factor (IGF)1, IGF2 and H19. Using pyrosequencing, methylation status was determined by quantifying cystosine:thymine ratios at 35 individual CpG sites. Plasma IGF1/insulin levels were measured by RIA.

Results There were no significant differences in DNA methylation between Ad.VEGF and Saline groups, except at 1 of 4 CpG dinucleotides preceding IGF2 exon-6 (3.8 ± 0.59 vs. 1.9 ± 0.60%, p = 0.029). Irrespective of treatment, insulin gene methylation was greater in males than females (88.7 ± 0.23 vs. 87.0 ± 0.50%, p = 0.007) and negatively correlated with fasting insulin levels (r = –0.431, n = 28, p = 0.022). By contrast, IGF1 methylation tended to be lower in males than females (84.3 ± 0.16 vs. 84.8 ± 0.22%, p = 0.053) and was unrelated to plasma IGF1 levels.

Conclusion Increased postnatal growth rates in Ad.VEGF-treated lambs most likely reflect their relative size advantage at birth rather than altered epigenetic status of key somatotropic genes.

References

  1. Carr DJ, Aitken RP, Milne JS, et al. Maternal Ad.VEGF gene therapy increases fetal growth velocity in growth restricted sheep fetuses. BJOG 2011;118:1008-1009.

  2. Carr DJ, Aitken RP, Milne JS, et al. Prenatal gene therapy increases fetal growth velocity and alters uterine artery vascular reactivity in the absence of a measurable effect on uterine blood flow in a sheep model of fetal growth restriction. Archives of Disease in Childhood: Fetal and Neonatal Edition 2012;97(Suppl_1):A1.

  3. Carr DJ, Aitken RP, Milne JS, et al. Alterations in postnatal growth and metabolism following prenatal treatment of intrauterine growth restriction with Ad.VEGF gene therapy in the sheep. Archives of Disease in Childhood: Fetal and Neonatal Edition 2011;96(Suppl1):Fa7.

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.